Patricia Valerio

MaxWell Monthly Must-Reads | Amyotrophic Lateral Sclerosis

Welcome to our MaxWell Monthly Must-Reads blog for February 2022. After last months edition about retinal organoids we have arrived at the second blog. We have picked another theme this month and selected five papers that we have read including publications using our MaxOne and MaxTwo system. In February, we have decided to focus on ALS research. The deliberating neurodegenerative disease that forced the “The Iron Horse” (-Lou Gehrig, one of the most decorated baseball legends) to retire is medically known…

Read More

MaxWell Monthly Must-Reads | Retinal Organoids

Welcome to our MaxWell Monthly Must-Reads blog for 2022. A new year also means new publications to highlight and new topics to discover. This year as well, for our monthly must-reads, we will choose a theme per month and select five papers that we think are worth reading. Last year we covered a range of topics and in our first edition of 2022, we have decided to focus on Retinal Organoids. Human brain organoids assemble functionally integrated bilateral optic vesicles.…

Read More

HyVIS project

MaxWell Biosystems Becomes a Key Partner in a €3M EU-Financed Project “HyVIS”: Next Generation Prosthesis for Visual Restoration Hybrid Synapse for Vision (HyVIS) is a project funded by European Union Horizon 2020 FET-OPEN program 1, which aims to combine several technologies to achieve the groundbreaking restoration of synaptic light-mediated input in retinas with impaired photoreceptors, leading to treatments for diseases such as in retinitis pigmentosa and age-related macular degeneration (AMD). The key focus of HyVIS project is the development of an artificial light-sensitive prosthesis,…

Read More

MaxWell Monthly Must-Reads | High-Throughput Screening

It is time for a new edition of our monthly blog. In the August edition during the summer holidays, we highlighted the latest developments on CMOS-based MEA technology. For the September edition, we decided to focus on high-throughput screening. With these articles, we would like to prepare you for our upcoming webinar which will be a live demo of our multiwell MEA system, MaxTwo. You can still register for this live demonstration here. In this Monthly Must-Reads edition, we highlighted…

Read More

MaxWell Monthly Must-Reads | CMOS-Based MEA Technology

  It is time for a new edition of our monthly blog. In the August edition during the summer holidays, we highlight the latest developments on CMOS-based MEA technology. CMOS-based MEAs are used for detailed investigations of neuronal electrical activity at network and single-cell levels and to evaluate the effect of drugs on neuronal physiological activity. Therefore, for this Monthly Must-Reads edition, we decided to highlight the article written by Yuan X et al., in which switch-matrix (SM) and active-pixel-sensors…

Read More
Contact Us






Albisriederstrasse 253
8047 Zurich, Switzerland
+41 44 244 24 24
Schedule a call
info@mxwbio.com
Subscribe to our Newsletter